Post-Grant Review Petitioner:  Cancer Treatment Patent Is Obvious

Mealey's (November 14, 2019, 1:04 PM EST) -- ALEXANDRIA, Va. — In a Nov. 11 petitioner reply filed with the Patent Trial and Appeal Board, a petitioner for post-grant review (PGR) of a cancer treatment patent maintains its position...
To view the full article, register now.